Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Unfortunately I was here long enough to experience those fumbles. Uplisting aside, I still remember Leo applying for a Kevetrin grant for prostate cancer or submitting a Kevetrin paper for peer review, then crickets. The application for Breakthrough Therapy Designation for B-OM was also a failure. Here’s a more recent example.

On a related note, the Company has submitted a preliminary summary of Brilacidin’s potential as a novel coronavirus treatment to the Biomedical Advanced Research and Development Authority (BARDA), which is dedicated to rapidly identifying and funding medical countermeasures to the COVID-19 outbreak.

http://www.ipharminc.com/press-release/2020/2/24/innovation-pharmaceuticals-submits-material-transfer-agreement-to-study-lead-defensin-mimetic-brilacidin-for-coronavirus-covid-19

Below is a list of companies and the amount awarded by BARDA to fight COVID-19.

https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx

Four months later, crickets. Investors should ask themselves if B is so promising against COVID-19, why hasn’t BARDA worked with IPIX directly? Remember in vitro data were released in April and the government is moving at “warp speed”. Instead you have Leo applying grant with a RBL on one hand and paying a university researcher on another hand.